UBS Group »

Aurinia Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 254k 8.99
2023-09-30 $1.5M 192k 7.75
2023-06-30 $2.3M 242k 9.68
2023-03-31 $1.4M 132k 10.96
2022-12-31 $201k 47k 4.32
2022-09-30 $274k 37k 7.46
2022-06-30 $1.5M 150k 10.05
2022-03-31 $2.5M 205k 12.35
2021-12-31 $2.6M 114k 22.87
2021-09-30 $5.8M 263k 22.13
2021-06-30 $3.4M 260k 12.95
2021-03-31 $3.3M 255k 12.99
2020-12-31 $3.0M 216k 13.83
2020-09-30 $2.5M 169k 14.73
2020-06-30 $1.7M 102k 16.25
2020-03-31 $1.8M 122k 14.51
2019-12-31 $1.7M 83k 20.26
2019-09-30 $38k 7.1k 5.34
2019-06-30 $42k 6.4k 6.52
2019-03-31 $46k 7.0k 6.55
2018-12-31 $53k 8.2k 6.44
2018-09-30 $862k 129k 6.68
2018-06-30 $678k 120k 5.63
2018-03-31 $599k 115k 5.19
2017-12-31 $538k 119k 4.53
2017-09-30 $582k 93k 6.27
2017-06-30 $604k 99k 6.13
2017-03-31 $824k 112k 7.34
2016-12-31 $208k 99k 2.10
2016-09-30 $209k 69k 3.01
2016-03-31 $6.0k 2.0k 2.97
2015-12-31 $42k 17k 2.48